日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B

阿特珠单抗联合贝伐珠单抗治疗Child-Pugh B级肝细胞癌患者的疗效和安全性

期刊:Liver International
影响因子:5.2
doi:10.1111/liv.70466
Sasaki, Ryu; Shimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Miuma, Satoshi; Shirono, Tomotake; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Kanayama, Yuki; Naganuma, Atsushi; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Miyaaki, Hisamitsu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

阿特珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者后序贯免疫检查点抑制剂再治疗的疗效

期刊:Journal of Gastroenterology and Hepatology
影响因子:3.4
doi:10.1111/jgh.70150
Ito, Takanori; Shimose, Shigeo; Saeki, Issei; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Miyaaki, Hisamitsu; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Takami, Taro; Kawaguchi, Takumi; Kawashima, Hiroki
Checkpoint
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Kupffer cell diversity maintains liver function in alcohol-associated liver disease.

库普弗细胞多样性维持酒精性肝病中的肝功能

期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000000918
Sasaki Kyo, Rooge Sheetalnath, Gunewardena Sumedha, Hintz Janice Averilla, Ghosh Priyanka, Pulido Ruiz Isabel Aranzazu, Yuquimpo Kyle, Schonfeld Michael, Mehta Heer, Stevenson Heather L, Saldarriaga Omar A, Arroyave Esteban, Tikhanovich Irina, Wozniak Ann L, Weinman Steven A
细胞生物学
发表日期：2025
文献求助 收藏

Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy

甲胎蛋白和去γ-羧基凝血酶原可以预测接受度伐利尤单抗联合曲美利尤单抗治疗的肝细胞癌患者的客观疗效。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0311084
Saeki, Issei; Shimose, Shigeo; Tomonari, Tetsu; Ito, Takanori; Tani, Joji; Takeuchi, Yasuto; Yoshioka, Naoki; Naito, Takehito; Takeuchi, Mamiko; Kakizaki, Satoru; Hatanaka, Takeshi; Sasaki, Kyo; Yasunaka, Tetsuya; Sakata, Masahiro; Iwamoto, Hideki; Itano, Satoshi; Shirono, Tomotake; Tanabe, Norikazu; Yamamoto, Takafumi; Kanayama, Yuki; Naganuma, Atsushi; Nishina, Sohji; Otsuka, Motoyuki; Kobara, Hideki; Kawashima, Hiroki; Takayama, Tetsuji; Kawaguchi, Takumi; Yamasaki, Takahiro; Takami, Taro
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice

在真实世界实践中，度伐利尤单抗联合曲美利尤单抗治疗不可切除肝细胞癌患者的初步临床经验

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2024.14530
Shimose, Shigeo; Saeki, Issei; Tomonari, Tetsu; Ito, Takanori; Tani, Joji; Takeuchi, Yasuto; Yoshioka, Naoki; Naito, Takehito; Takeuchi, Mamiko; Kakizaki, Satoru; Hatanaka, Takeshi; Sasaki, Kyo; Yasunaka, Tetsuya; Sakata, Masahiro; Iwamoto, Hideki; Itano, Satoshi; Shirono, Tomotake; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Nishina, Soji; Otsuka, Motoyuki; Kawashima, Hiroki; Takayama, Tetsuji; Takami, Taro; Kawaguchi, Takumi
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Skill Proficiency, Efficacy, and Safety of the Transradial Approach in Transarterial Treatments for Hepatocellular Carcinoma

经桡动脉入路治疗肝细胞癌的技能熟练度、疗效和安全性

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.57800
Sasaki, Kyo; Kawamura, Yusuke; Ogawa, Chikara; Yabushita, Kazuhisa; Watanabe, Shoji; Hayashi, Hideki; Kochi, Takahiro; Tomonari, Tetsu; Ninomiya, Masashi; Takai, Koji; Imajo, Kento; Ito, Takanori; Kita, Ryuichi; Mawatari, Seiichi; Nishina, Sohji; Toyoda, Hidenori
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report

长期放血疗法成功缓解了SLC40A1基因突变型铁转运蛋白病患者的肝脏铁沉积：病例报告

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-021-01674-z
Nishina, Sohji; Tomiyama, Yasuyuki; Ikuta, Katsuya; Tatsumi, Yasuaki; Toki, Yasumichi; Kato, Ayako; Kato, Koichi; Yoshioka, Naoko; Sasaki, Kyo; Hara, Yuichi; Hino, Keisuke
发表日期：2021
文献求助 收藏